Listing 1 - 10 of 74 | << page >> |
Sort by
|
Choose an application
For more than 50 years, Dubois' Lupus Erythematosus and Related Syndromes has been recognized internationally as the go-to clinical reference on lupus and other connective tissue diseases. From basic scientific principles to practical points of clinical management, the 10th edition provides extensive, authoritative coverage of systemic lupus erythematosus (SLE) and its related diseases in a logical, clearly written, user-friendly manner. It's an ideal resource for rheumatologists and internal medicine practitioners who need a comprehensive clinical reference on all aspects of SLE, connective tissue diseases, and the antiphospholipid syndromes.
Choose an application
Systemic lupus erythematosus (SLE) affects predominantly women at reproductive age but may present at any age. Age at disease onset has a modulating effect on presentation and course of disease, but controversies persist regarding its impact on long-term outcome. Our aims were to characterize clinical features, co-morbidities and cumulative damage in childhood-onset, adult-onset and late-onset SLE. Patients with childhood-onset SLE fulfilling ACR 1997 criteria were identified in a nationwide register-Reuma.pt/SLE (N = 89) and compared with adult-onset and late-onset counterparts matched 1:1:1 for disease duration. 267 SLE patients with mean disease duration of 11.9 ± 9.3 years were analyzed. Skin (62 %), kidney (58 %), neurological (11 %) and hematologic involvement (76 %) were significantly more common in childhood-onset SLE and disease activity was higher in this subset than in adult- and late-onset disease (SLEDAI-2K 3.4 ± 3.8 vs. 2.2 ± 2.7 vs. 1.6 ± 2.8, respectively; p = 0.004). Also, more childhood-onset patients received cyclophosphamide (10 %) and mycophenolate mofetil (34 %). A greater proportion of women (96 %), prevalence of arthritis (89 %) and anti-SSA antibodies (34 %) were noted in the adult-onset group. There was a significant delay in the diagnosis of SLE in older ages. Co-morbidities such as hypertension, diabetes and thyroid disease were significantly more frequent in late-onset SLE, as well as the presence of irreversible damage evaluated by the SLICC/ACR damage index (20 vs. 26 vs. 40 %; p < 0.001). Greater organ involvement as well as the frequent need for immunosuppressants supports the concept of childhood-onset being a more severe disease. In contrast, disease onset is more indolent but co-morbidity burden and irreversible damage are greater in late-onset SLE, which may have implications for patients' management.
Lupus erythematosus. --- Cutaneous lupus erythematosus --- Skin --- Diseases
Choose an application
Choose an application
This Edited Volume "Systemic Lupus Erythematosus - Pathogenesis" and Management" is a collection of reviewed and relevant research chapters, offering a comprehensive overview of recent developments in the field of lupus erythematosus. The book comprises single chapters authored by various researchers and edited by an expert active in the lupus research area. All chapters are complete in themselves but united under a common research study topic. This publication aims at providing a thorough overview of the latest research efforts by international authors on lupus, and open new possible research paths for further novel developments.
Choose an application
Choose an application
Choose an application
Choose an application
Choose an application
Systemic lupus erythematosus (SLE) is a multisystem, immune-mediated, inflammatory disease of unknown etiology. It is difficult to diagnose and thus effective intervention in SLE patients is often delayed. This book is a comprehensive guide to lupus, with chapters on diagnosis, assessment, treatment, the link between lupus and endocrinopathies, lupus and pregnancy, and advances in therapeutics. The book is presented by devoted authors who sought the latest evidence-based data to provide a well-structured display aiming at setting standards for best practice guidelines in the diagnosis and management of each and every section discussed in the "Lupus- Need to Know."
Choose an application
Lupus Erythematosus, Discoid. --- Lupus Erythematosus, Systemic. --- Lupus erythematosus --- Systemic lupus erythematosus --- Libman-Sacks disease --- Lupus (Systemic lupus erythematosus) --- Lupus erythematosus, Systemic --- Lupus erythematosus disseminatus --- SLE (Disease) --- Autoimmune diseases --- Blood-vessels --- Collagen diseases --- Skin --- Cutaneous lupus erythematosus --- Libman-Sacks Disease --- Lupus Erythematosus Disseminatus --- Systemic Lupus Erythematosus --- Disease, Libman-Sacks --- Libman Sacks Disease --- Lupus Erythematosus, Chronic Cutaneous --- Lupus Erythematosus, Cutaneous, Chronic --- Discoid Lupus Erythematosus --- Diseases --- Lupus erythematosus. --- Systemic lupus erythematosus. --- Lupus Erythematosus, Discoid --- Lupus Erythematosus, Systemic
Listing 1 - 10 of 74 | << page >> |
Sort by
|